Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Atrogin-1 promotes muscle homeostasis by regulating levels of endoplasmic reticulum chaperone BiP
Avnika A. Ruparelia, Margo Montandon, Jo Merriner, Cheng Huang, Siew Fen Lisa Wong, Carmen Sonntag, Justin P. Hardee, Gordon S. Lynch, Lee B. Miles, Ashley Siegel, Thomas E. Hall, Ralf B. Schittenhelm, Peter D. Currie
Avnika A. Ruparelia, Margo Montandon, Jo Merriner, Cheng Huang, Siew Fen Lisa Wong, Carmen Sonntag, Justin P. Hardee, Gordon S. Lynch, Lee B. Miles, Ashley Siegel, Thomas E. Hall, Ralf B. Schittenhelm, Peter D. Currie
View: Text | PDF
Research Article Muscle biology

Atrogin-1 promotes muscle homeostasis by regulating levels of endoplasmic reticulum chaperone BiP

  • Text
  • PDF
Abstract

Skeletal muscle wasting results from numerous pathological conditions affecting both the musculoskeletal and nervous systems. A unifying feature of these pathologies is the upregulation of members of the E3 ubiquitin ligase family, resulting in increased proteolytic degradation of target proteins. Despite the critical role of E3 ubiquitin ligases in regulating muscle mass, the specific proteins they target for degradation and the mechanisms by which they regulate skeletal muscle homeostasis remain ill-defined. Here, using zebrafish loss-of-function models combined with in vivo cell biology and proteomic approaches, we reveal a role of atrogin-1 in regulating the levels of the endoplasmic reticulum chaperone BiP. Loss of atrogin-1 resulted in an accumulation of BiP, leading to impaired mitochondrial dynamics and a subsequent loss in muscle fiber integrity. We further implicated a disruption in atrogin-1–mediated BiP regulation in the pathogenesis of Duchenne muscular dystrophy. We revealed that BiP was not only upregulated in Duchenne muscular dystrophy, but its inhibition using pharmacological strategies, or by upregulating atrogin-1, significantly ameliorated pathology in a zebrafish model of Duchenne muscular dystrophy. Collectively, our data implicate atrogin-1 and BiP in the pathogenesis of Duchenne muscular dystrophy and highlight atrogin-1’s essential role in maintaining muscle homeostasis.

Authors

Avnika A. Ruparelia, Margo Montandon, Jo Merriner, Cheng Huang, Siew Fen Lisa Wong, Carmen Sonntag, Justin P. Hardee, Gordon S. Lynch, Lee B. Miles, Ashley Siegel, Thomas E. Hall, Ralf B. Schittenhelm, Peter D. Currie

×

Figure 5

BiP accumulation is also responsible for the impaired mitochondrial dynamics.

Options: View larger image (or click on image) Download as PowerPoint
BiP accumulation is also responsible for the impaired mitochondrial dyna...
Live images of 6 dpf DMSO- (A and B), tunicamycin- (Tm-) (C and D), or thapsigargin-treated (Tg-treated) (E and F) larvae showing mosaic expression of actc1b:mitoGFP labeling the mitochondria in green. While DMSO-treated larvae display small mitochondria, some of which form an intricate network, mitochondria in Tm- and Tg-treated larvae were large and rounded, as determined using a χ2 test. B, D, and F (scale bar: 15 μm) are zoomed in views of A, C, and E (scale bar: 100 μm), respectively. (G) The proportion of muscle fibers displaying altered mitochondrial morphology following DMSO, Tm, or Tg treatment, determined using a χ2 test. (H–O) Live images of 6 dpf larvae coexpressing Mito-GFP with mCherry (H–K) or BiP-mCherry (L–O). K and O are zoomed in views of J and N, respectively. Scale bar: 150 μm (first, second, and third columns); 15 μm (last column). (P) The proportion of muscle fibers displaying altered mitochondrial morphology comparing mCherry overexpression with BiP overexpression, as per Fisher’s exact test. (Q and R) Live images of 6 dpf atrogin-1–/– mutant larvae on the Tg(actc1b:KalTA4;cryaa:GFPpc54Tg) only (labeled as Control (KaltA4)) or Tg(actc1b:KalTA4;cryaa:GFPpc54Tg) and Tg(4XUAS:NLSCas9;cmlc2:RFP gl37Tg) (labeled as BiP KO) background, showing mosaic expression of actc1b:mitoGFP labeling the mitochondria in green. While control atrogin-1–/– mutants display large and rounded mitochondria, atrogin-1–/– mutants with BiP deficiency specifically in the muscle have small mitochondria that form an intricate network, as determined using a χ2 test. Scale bar: 100 μm. (S) The proportion of muscle fibers displaying altered mitochondrial morphology in control and BiP-KO atrogin-1–/– mutants, as per Fisher’s exact test. *P < 0.05, ***P < 0.001. All experiments performed in triplicate with the total number of fish examined in each replicate being documented in Supplemental Table 2.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts